Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 4, Avril 2011
Page(s) 443 - 446
Section Dernière heure
DOI https://doi.org/10.1051/medsci/2011274023
Publié en ligne 28 avril 2011
  1. MarteynA, MauryY, GauthierMM, et al. Mutant human embryonic stem cells reveal neurite and synapse formation defects in Type 1 myotonic dystrophy. Cell Stem Cell 2011 ; online.
  2. EigesR, UrbachA, MalcovM, et al. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007 ; 5 : 568-577. [CrossRef]
  3. TakahashiK, TanabeK, OhnukiM, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. cell 2007 ; 5 : 861-872. [CrossRef] [PubMed]
  4. GoreA, LiZ, FungHL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011 ; 471 : 63-67. [CrossRef] [PubMed]
  5. HusseinSM, BatadaNN, VuoristoS, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011 ; 471 : 58-62. [CrossRef] [PubMed]
  6. ListerR, PelizzolaM, KidaYS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011 ; 471 : 68-73. [CrossRef] [PubMed]
  7. UrbachA, Bar-NurO, DaleyGQ, BenvenistyN.. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2007 ; 5 : 407-411.
  8. RanumLP, CooperTA.. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 2006 ; 29 : 259-277. [CrossRef] [PubMed]
  9. JiangH, MankodiA, SwansonMS, et al. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 2004 ; 24 : 3079-3088. [CrossRef]
  10. StranockSD, DavisJN.. Ultrastructure of the muscle spindle in dystrophia myotonica. II. The sensory and motor nerve terminals. Neuropathol Appl Neurobiol 1978 ; 5 : 407-418. [CrossRef]
  11. PanaitePA, GanteletE, KraftsikR, et al. Myotonic dystrophy transgenic mice exhibit pathologic abnormalities in diaphragm neuromuscular junctions and phrenic nerves. J Neuropathol Exp Neurol 2008 ; 8 : 763-772. [CrossRef]
  12. NagaoM, KatoS, HayashiH, MisawaH.. Hyperproliferation of synapses on spinal motor neurons of Duchenne muscular dystrophy and myotonic dystrophy patients. Acta Neuropathol 2003 ; 6 : 557-560. [CrossRef]
  13. ParkIH, AroraN, HuoH, et al. Disease-specific induced pluripotent stem cells. Cell 2008 ; 134 : 877-886. [CrossRef] [PubMed]
  14. KazukiY, HiratsukaM, TakiguchiM, et al. Complete genetic correction of ips cells from Duchenne muscular dystrophy. Mol Ther 2009 ; 2 : 386-393.
  15. SoldnerF, HockemeyerD, BeardC, et al. disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009 ; 5 : 964-977. [CrossRef]
  16. HargusG, CooperO, DeleidiM, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 2010 ; 107 : 15921-15926. [CrossRef]
  17. MaehrR, ChenS, SnitowM, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 2009 ; 37 : 15768-15773. [CrossRef]
  18. BaekKH, ZaslavskyA, LynchRC, et al. Down’s syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 2009 ; 7250 : 1126-1130. [CrossRef]
  19. EbertAD, YuJ, RoseFFJr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009 ; 7227 : 277-280. [CrossRef] [PubMed]
  20. LeeG, PapapetrouEP, KimH, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009 ; 7262 : 402-406. [CrossRef]
  21. DimosJT, RodolfaKT, NiakanKK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008 ; 5893 : 1218-1221. [CrossRef] [PubMed]
  22. HottaA, CheungAY, FarraN, et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009 ; 5 : 370-376. [CrossRef]
  23. MarchettoMC, CarromeuC, AcabA, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010 ; 4 : 527-539. [CrossRef] [PubMed]
  24. CheungAY, HorvathLM, GrafodatskayaD, Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet 2011, 17 mars (online).
  25. YeL, ChangJC, LinC, et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 2009 ; 24 : 9826-9830. [CrossRef]
  26. WangY, JiangY, LiuS, et al. Generation of induced pluripotent stem cells from human beta-thalassemia fibroblast cells. Cell Res 2009 ; 9 : 1120-1123. [CrossRef]
  27. ZhangJ, LianQ, ZhuG, et al. A human iPSC model of Hutchinson-Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2010 ; 1 : 31-45.
  28. LiuGH, BarkhoBZ, RuizS, et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011, 23 février(online).
  29. MorettiA, BellinM, WellingA, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010 ; 15 : 1397-1409. [CrossRef]
  30. ItzhakiI, MaizelsL, HuberI, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011 ; 7337 : 225-229. [CrossRef]
  31. MatsaE, RajamohanD, DickE, et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur Heart J 2011 ; 2 mars (online).
  32. YazawaM, HsuehB, JiaX, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011 ; 7337 : 230-234. [CrossRef]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.